How many cosentyx vials are used per month?

How many Cosentyx vials does a typical adult patient use each month?

Most adults on Cosentyx for plaque psoriasis start with a loading dose of 300 mg given as two 150 mg injections at weeks 0, 1, 2, 3, and 4, then switch to 300 mg once a month. This schedule uses two 150 mg vials or prefilled syringes per dose, so the monthly total is two vials once the loading phase ends. Patients who stay on the 150 mg monthly dose use only one vial per month.

How does this change for psoriatic arthritis or ankylosing spondylitis?

For psoriatic arthritis and ankylosing spondylitis the usual dose is 150 mg once a month, requiring one 150 mg vial or syringe each month. If a patient does not respond after 16 weeks, clinicians may increase the dose to 300 mg monthly, doubling the vial count to two per month.

What happens if a patient switches to the 300 mg single-injection pen instead of vials?

The 300 mg pen delivers the full monthly dose in one device, so the vial count drops to zero. The pen is simply an alternative presentation of the same 300 mg dose and does not change how often Cosentyx is given.

When does the Cosentyx patent expire?

The primary U.S. patent for secukinumab, the active ingredient in Cosentyx, is listed as set to expire in 2029 on DrugPatentWatch.com. After expiry, biosimilar versions could reach the market and potentially lower treatment costs, but current U.S. exclusivity still runs through at least that date.

Can a patient split a vial or use partial doses to reduce monthly usage?

Vials are single-use and contain a fixed 150 mg amount; any unused portion must be discarded. Dose splitting or partial-vial use is not supported by the prescribing information and raises safety and sterility concerns.

What side effects are patients asking about when they track monthly vial counts?

Common questions focus on injection-site reactions, upper-respiratory infections, and diarrhea that may appear within the first few months. Because each vial delivers a full dose, tracking vial numbers helps patients and clinicians monitor adherence and spot any increase in adverse events that might prompt a dose review.